Serum vancomycin levels predict the short-term adverse outcomes of peritoneal dialysis–associated peritonitis

Ying Ma, Yingzhou Geng, Li Jin, Xiaopei Wang, Changna Liang, Liyi Xie, Wanhong Lu & Jing Lv
Background:The role of monitoring serum vancomycin levels during treatment of peritoneal dialysis (PD)–associated peritonitis is controversial. Substantial inter-individual variability may result in suboptimal serum levels despite similar dosing of vancomycin. The published predictors of suboptimal serum vancomycin levels remain limited.Methods:Data were retrospectively collected from 541 patients on continuous ambulatory peritoneal dialysis between 1 January 2018 and 31 December 312019. For gram-positive cocci and culture-negative peritonitis, we adopted a vancomycin administration and monitoring protocol. Short-term adverse...
1 citation reported since publication in 2022.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.